West Pharmaceutical Services Inc (WST)

Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell

$203.40

Buy

$219.99

arrow-up$3.99 (+1.93%)

West Pharmaceutical Services Inc develops, manufactures and sells packaging components and systems for injectable drug delivery, including stoppers and seals for vials, closures and other components used in syringe, and prefillable syringe components.
Prices updated at 15 May 2025, 21:42 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-up0.41%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Mr. Eric Mark Green
CEO
Mr. Eric Mark Green
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
10,600
Head office
530 Herman O. West Drive
Exton
United States
19341-1147
mobile
+1 610 594-2900
letter
Quintin.Lai@westpharma.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Bernard J. Birkett
Senior Vice President and Chief Financial Officer
0.72m--3.14m-
Ms. Kimberly Banks MacKay
Senior Vice President, General Counsel and Corporate Secretary
0.48m--1.23m-
Mr. Shane Campbell
Senior Vice President and Chief Proprietary Segment Officer
-----
Ms. Deborah L.V. Keller
Independent Director
0.12m--0.34m-
Mr. Douglas A. Michels
Independent Director
0.10m--0.36m-
Mr. Paolo Pucci
Lead Independent Director
0.14m--0.37m-
Mr. Robert F. Friel
Independent Director
0.12m--0.34m-
Mr. Thomas W. Hofmann
Independent Director
0.13m--0.39m-
Ms. Janet Brutschea Haugen
Independent Director
0.01m--0.09m-
Mr. Mark A. Buthman
Independent Director
0.12m--0.38m-
Dr. Myla P. Lai-Goldman,M.D.
Independent Director
0.12m--0.36m-
Mr. Eric Mark Green
Chief Executive Officer, President and Chairman of the Board
1.17m--8.39m-
Dr. William F. Feehery, PhD
Independent Director
0.10m--0.36m-
Ms. Annette F. Favorite
Senior Vice President and Chief Human Resources Officer
0.45m--1.25m-
Ms. Molly E. Joseph
Independent Director
0.10m--0.33m-
Mr. Chad R. Winters
Vice President, Finance and Chief Accounting Officer
-----
Dr. Stephen H. Lockhart, PhD
Independent Director
0.10m--0.33m-
Mr. Quintin J. Lai
Vice President, Strategy and Investor Relations
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc9,231,7210.037372442592.71777530 Apr 202512.85
BlackRock Inc6,930,1190.03259-520601-6.98725830 Apr 20259.65
Bank of New York Mellon Corp3,449,8110.208712031986.25876930 Apr 20254.80
Brown Advisory Holdings Inc3,268,4781.0457671644228.0733530 Apr 20254.55
State Street Corp3,246,7130.04196322651.00374930 Apr 20254.52

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
16 Dec 2024-Ms. Janet Brutschea Haugen--247--
29 Oct 2024-Mr. Silji Abraham--3,318--
29 Oct 2024-Mr. Silji Abraham-----
29 Oct 2024-Mr. Silji Abraham318.4157,3873,138--
06 Aug 2024-Eric Mark Green59.64357,840167,898--
06 Aug 2024-Eric Mark Green59.641,832,856192,640--
06 Aug 2024-Eric Mark Green-----
06 Aug 2024-Eric Mark Green--6,000--
06 Aug 2024-Eric Mark Green304.719,364,409161,898--
12 Jun 2024-Mr. Silji Abraham330.78595,4042,860--
10 May 2024-Mr. Thomas W. Hofmann365.92225,77343,565--
07 May 2024-Eric Mark Green--36,732--
07 May 2024-Eric Mark Green--45,732--
07 May 2024-Eric Mark Green-----
07 May 2024-Eric Mark Green-----
07 May 2024-Eric Mark Green59.64536,760161,908--
07 May 2024-Eric Mark Green366.6515,032,736152,908--
07 May 2024-Eric Mark Green366.665,750,678193,908--
07 May 2024-Eric Mark Green366.643,415,636209,952--
07 May 2024-Eric Mark Green59.642,445,240218,908--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.